Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1986 Jun 14;292(6535):1548–1549. doi: 10.1136/bmj.292.6535.1548

Morphine intoxication in renal failure: the role of morphine-6-glucuronide.

R J Osborne, S P Joel, M L Slevin
PMCID: PMC1340555  PMID: 3087512

Abstract

Patients with impaired renal function may experience severe and prolonged respiratory depression when treated with morphine. This has been attributed to accumulation of the drug during renal failure. Three patients are described who had classical signs of intoxication with morphine in the absence of measurable quantities of morphine in the plasma. The observed clinical effect is attributed to accumulation of the pharmacologically active metabolite morphine-6-glucuronide, which is usually renally excreted. It is concluded that morphine does not accumulate in patients with renal failure but that accumulation of metabolites does occur. The previously reported observations of morphine accumulation during renal failure probably result from the use of radioimmunoassays that cannot distinguish between morphine and morphine-6-glucuronide. Thus the apparent morphine concentration measured with these assays in fact reflects the total quantity of morphine and morphine-6-glucuronide present.

Full text

PDF
1548

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aherne G. W., Littleton P. Morphine-6-glucuronide, an important factor in interpreting morphine radioimmunoassays. Lancet. 1985 Jul 27;2(8448):210–211. doi: 10.1016/s0140-6736(85)91519-3. [DOI] [PubMed] [Google Scholar]
  2. Ball M., McQuay H. J., Moore R. A., Allen M. C., Fisher A., Sear J. Renal failure and the use of morphine in intensive care. Lancet. 1985 Apr 6;1(8432):784–786. doi: 10.1016/s0140-6736(85)91448-5. [DOI] [PubMed] [Google Scholar]
  3. Joel S. P., Osborne R. J., Nixon N. S., Slevin M. L. Morphine-6-glucuronide, an important metabolite. Lancet. 1985 May 11;1(8437):1099–1100. doi: 10.1016/s0140-6736(85)92397-9. [DOI] [PubMed] [Google Scholar]
  4. Shimomura K., Kamata O., Ueki S., Ida S., Oguri K. Analgesic effect of morphine glucuronides. Tohoku J Exp Med. 1971 Sep;105(1):45–52. doi: 10.1620/tjem.105.45. [DOI] [PubMed] [Google Scholar]
  5. Svensson J. O., Rane A., Säwe J., Sjöqvist F. Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography. J Chromatogr. 1982 Jul 9;230(2):427–432. doi: 10.1016/s0378-4347(00)80494-6. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES